Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Botanical

or Dissociative

or TCA

Use the filters below to narrow your results.

None (40) · Anafranil (1) · DXM (1) · DXO (1) · Ludiomil (1) · Norpramin (1) · Spravato (1) · Surmontil (1) · Tofranil (1) · Vivactil (1)

NMDA antagonist (3) · Serotonin and norepinephrine reuptake inhibitor (3) · Contains LSA (2) · Contains mescaline (2) · NMDA antagonist; sigma receptor agonist (2) · Selective norepinephrine reuptake inhibitor (2)

Other values:

None (48) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1)

None (48) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1)

None (48) · 28 mg/device (each dose uses 2 devices) (1)

None (48) · 84 mg per session (1)

None (48) · Intranasal (under direct medical supervision) (1)

None (48) · Within hours of first administration (1)

None (48) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1)

None (48) · ~7-12 hours (1)

None (48) · ~48% intranasal (1)

None (48) · Avoid; may cause fetal harm (1)

None (48) · Rx, Schedule III (US). REMS program required. (1)

Showing below up to 50 results in range #1 to #50.

2

2-FDCK

3

4

4-MeO-PCP

7

7-Hydroxymitragynine

A

B

Blue lotus

C

D

E

H

I

K

Kava
Kratom

M

N

Nitrous oxide

O

O-PCE

P

S

T

X

Xenon

Y

Yopo